HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis.

AbstractOBJECTIVE:
To examine whether sodium pump activity plays a part in the pathogenesis of thyrotoxic periodic paralysis.
DESIGN:
Measurement of platelet sodium-potassium ATPase and in vivo sodium pump activities in healthy subjects and thyrotoxic subjects with and without paralysis.
SETTING:
University hospital in Hong Kong.
SUBJECTS:
21 healthy subjects, 23 untreated thyrotoxic subjects, 13 untreated men with periodic paralysis, seven treated thyrotoxic subjects, and six treated men with periodic paralysis.
MAIN OUTCOME MEASURES:
Platelet Na+, K(+)-ATPase activity and plasma rubidium concentration after oral loading.
RESULTS:
Median (range) platelet Na+, K(+)-ATPase activity in thyrotoxic subjects was 253 (169-821) mumol inorganic phosphate/h/g protein--significantly higher than that in healthy subjects (134 (81-180) mumol/h/g protein; p less than 0.001). Na+, K(+)-ATPase activity in those with periodic paralysis was 374 (195-1196) mumol/h/g protein, again significantly higher than that in healthy subjects (p less than 0.001) and that in other thyrotoxic subjects (p less than 0.01) despite similar degrees of hyperthyroidism. Activities in treated thyrotoxic subjects with and without periodic paralysis were 148 (110-234) and 131 (86-173) mumol/h/g protein respectively. Mean (95% confidence interval) plasma rubidium concentration five hours after oral administration in thyrotoxic subjects (7.0 (6.6 to 7.5) mumol/l) was significantly lower than in healthy subjects (10.2 (9.5 to 10.9) mumol/l; p less than 0.001) and higher than in those with periodic paralysis (6.0 (5.7 to 6.3) mumol/l; p less than 0.01).
CONCLUSIONS:
Sodium pump activity in untreated subjects with periodic paralysis is higher than in other thyrotoxic subjects, and this may be responsible for the hypokalaemia.
AuthorsA Chan, R Shinde, C C Chow, C S Cockram, R Swaminathan
JournalBMJ (Clinical research ed.) (BMJ) Vol. 303 Issue 6810 Pg. 1096-9 (Nov 02 1991) ISSN: 0959-8138 [Print] England
PMID1660744 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Triiodothyronine
  • Thyrotropin
  • Sodium-Potassium-Exchanging ATPase
  • Rubidium
  • Thyroxine
Topics
  • Adult
  • Blood Platelets (enzymology)
  • Humans
  • Male
  • Paralysis (blood, enzymology)
  • Periodicity
  • Rubidium (blood)
  • Sodium-Potassium-Exchanging ATPase (metabolism, physiology)
  • Thyrotoxicosis (blood, enzymology)
  • Thyrotropin (blood)
  • Thyroxine (blood)
  • Triiodothyronine (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: